Greg Russotti, PhD Celgene

Gregory Russotti is currently Vice President of Cell Therapy Development and Operations at Celgene Corporation, responsible for process development, analytical method development, clinical manufacturing, quality control and quality operations of cell therapy products.

Prior to joining Celgene in 2006, Greg spent nearly 15 years at Merck Research Laboratories developing products that included live virus vaccines, monoclonal antibodies, recombinant vaccines, and microbially-produced natural products. He worked on development, scale-up, and tech transfer of cell culture, microbial fermentation, and downstream isolation processes to clinical and commercial manufacturing facilities.

Greg received his B.S. and M.S. degrees in Chemical Engineering from Rensselaer Polytechnic Institute and his Ph.D. in Chemical and Biochemical Engineering from Rutgers University.